Fill out the form to get a free trial:
1Department of Molecular Cell Biology and Centre for Biomedial Genetics, Leiden University Medical Centre
Fill out the form to get a free trial:
An assay to quantitatively measure Transforming Growth Factor (TGF)-β-induced invasion in 3-dimensional collagen gels is described. This assay takes advantage of the MCF10A series of cell lines, which represent different stages of breast cancer development. This method can be adopted to be used with other cell lines and might be used to investigate other potential activators or inhibitors of invasion.
Naber, H. P., Wiercinska, E., ten Dijke, P., van Laar, T. Spheroid Assay to Measure TGF-β-induced Invasion. J. Vis. Exp. (57), e3337, doi:10.3791/3337 (2011).
TGF-β has opposing roles in breast cancer progression by acting as a tumor suppressor in the initial phase, but stimulating invasion and metastasis at later stage1,2. Moreover, TGF-β is frequently overexpressed in breast cancer and its expression correlates with poor prognosis and metastasis 3,4. The mechanisms by which TGF-β induces invasion are not well understood.
TGF-β elicits its cellular responses via TGF-β type II (TβRII) and type I (TβRI) receptors. Upon TGF-β-induced heteromeric complex formation, TβRII phosphorylates the TβRI. The activated TβRI initiates its intracellular canonical signaling pathway by phosphorylating receptor Smads (R-Smads), i.e. Smad2 and Smad3. These activated R-Smads form heteromeric complexes with Smad4, which accumulate in the nucleus and regulate the transcription of target genes5. In addition to the previously described Smad pathway, receptor activation results in activation of several other non-Smad signaling pathways, for example Mitogen Activated Protein Kinase (MAPK) pathways6.
To study the role of TGF-β in different stages of breast cancer, we made use of the MCF10A cell system. This system consists of spontaneously immortalized MCF10A1 (M1) breast epithelial cells7, the H-RAS transformed M1-derivative MCF10AneoT (M2), which produces premalignant lesions in mice8, and the M2-derivative MCF10CA1a (M4), which was established from M2 xenografts and forms high grade carcinomas with the ability to metastasize to the lung9. This MCF10A series offers the possibility to study the responses of cells with different grades of malignancy that are not biased by a different genetic background.
For the analysis of TGF-β-induced invasion, we generated homotypic MCF10A spheroid cell cultures embedded in a 3D collagen matrix in vitro (Fig 1). Such models closely resemble human tumors in vivo by establishing a gradient of oxygen and nutrients, resulting in active and invasive cells on the outside and quiescent or even necrotic cells in the inside of the spheroid10. Spheroid based assays have also been shown to better recapitulate drug resistance than monolayer cultures11. This MCF10 3D model system allowed us to investigate the impact of TGF-β signaling on the invasive properties of breast cells in different stages of malignancy.
1. Preparation of the methocel solution (500 mL)
2. Spheroid culture
3. Preparation of collagen
4. Spheroid embedding
5. Representative results:
An example of the spheroid assay with MCF10A1 (M1) normal breast epithelial cells, H-RAS transformed MCF10AneoT (M2) cells and M2-derived MCF10CA1a (M4) is given in Figure 3. M1 cells showed only weak invasion without stimulation, but invaded significantly better upon stimulation by TGF-β. In contrast, the RAS-transformed M1-derivative M2 invaded already efficiently without addition of stimuli, and this was further increased 4-5 fold upon TGF-β treatment. M4 cells showed the strongest invasion, both with and without TGF-β addition.
Next, we examined whether we could interfere with TGF-β-induced invasion in this spheroid model using chemical inhibitors. For this purpose we used SB-431542, an ATP analogue and selective inhibitor of the kinase activity of TβRI, as well as activin type IB receptor (ActRIB) and activin receptor-like kinase (ALK)712. As expected, SB-431542 potently inhibited TGF-β-induced invasion of M1, M2 and M4 cells (Fig 4), indicating that TGF-β-induced invasion is TβRI-kinase dependent. In addition, the basal invasion of the spheroids was also strongly inhibited, suggesting that basal invasion is also dependent on TGF-β.
Figure 1. Flow chart of the 3D spheroid assay. First, cells are plated under non-adherent conditions in u-shaped suspensions plates. Cells aggregrate into multcellular spheroids and can be embedded into a collagen matrix. Into this collagen matrix, they are able to invade.
Figure 2. Quantification of the area of the spheroids using Adobe Photoshop Extended. (A) The picture of the spheroid is opened in Adobe Photoshop Extendend (B) Selection of the Quick Selection tool (C) Dragging the cursor over the spheroid to select the area of the spheroid (D) Removal of a wongly included area using the negative Quick Selection tool (E) Adjustment of the brush size of the Quick Selection tool to more accurately select the area (F) Selection of the measurement command to record (G) Example of a measurement record.
Figure 3. TGF-β-induced invasion of spheroids of spontaneously immortalised MCF10A1 (M1) (A), RAS-transformed MCF10AneoT (M2 (B) and its metastatic derivative MCF10CA1a (M4) (C). M1, M2 and M4 spheroids embedded into collagen were treated with 5ng/ml of TGF-β for 48h as indicated. A-C Representative pictures taken at the day of embedding and two days later. D Relative invasion was quantified as area difference on day 2 minus day 0. The results are expressed as mean ± s.d. Adapted from13.
Figure 4. Basal and TGF-β-induced spheroid invasion is inhibited by SB-431542. M1, M2 and M4 spheroids were embedded into collagen and treated with 5ng/ml TGF-β and/or 10 μM SB-431542 as indicated. Representative pictures taken after 2 days (A). Relative invasion was quantified as area difference on day 2 minus day 0 (B). The results are expressed as mean ± s.d. Adapted from13.
We established a spheroid model in which MCF10A1 cells and its malignant derivatives invade into a collagen matrix in a TGF-β-dependent manner. First, spheroids are formed in 96-wells round bottom suspension plates in the presence of methylcellulose. Of course, also U-shaped poly-HEMA coated plates can be used for this purpose. Methylcellulose is absolutely required in this step, since cells will die in the absence of methylcellulose. TGF-β is added directly to the collagen-methocel mixture since we found that cells responded less well to the TGF-β when this factor was added to the medium op top of the collagen. However, it is advisable to add chemical inhibitors dissolved in DMSO not directly into the collagen, since the DMSO precipitates in the icecold collagen-methocel mixture. Therefore, we add these compounds in the medium on top of the collagen.
Subsequently, cells are embedded in a collagen 3-dimensional environment to allow them to invade into the collagen matrix. When comparing the invasive properties of the different MCF10A1 cell lines we found that basal invasion as well as TGF-β-induced invasion increased from the relatively benign M1 cells, to higher levels in the RAS-transformed M2 derivative, to even higher levels in the metastatic M4 variant. Thus, the invasive properties correlated with the relative state of aggressiveness of these three cell lines7,8,14.
The embedding of the spheroid into the collagen is a critical step in the assay. The detection of the spheroid in the pipette tip might be difficult when performing the assay for the first few times. One can avoid this by collecting the spheroids in a tube, spinning them down, removing supernatant and resuspend the spheroids in collagen-methocel mixture. This requires more spheroids as input as around 50% of the spheroids is lost during this process. Furthermore, multiple spheroids may end up in one well and might lie too close to each other to analyse. In addition, it is preferred to have not more then one spheroid per well to avoid the possibility that spheroids may interfere with each other (e.g. by secreting growth factors). Therefore the resuspension step is a critical step using this method.
A limitation of this assay is that we analyze a 3 dimensional assay in a 2 dimensional plane. As can be seen in Figures 3 and 4, most cells usually invade in the same plane. However, spheroids that are located very near the edge of the well invade generally more in depth and are for that reason excluded from the analysis. Of course it would be possible to perform the analysis in 3D, in order to get a more accurate result. But this requires sophisticated hardware and software and the benefit of calculating volume instead of using the area may not outweigh the trouble. Especially since we found that the variation in starting size of the 3-dimensional spheroids as measured in 2D, is generally only 5-10%.
Another disadvantage of this method is that the imaging is a time consuming step, since the spheroids are located at different heights, which hampers automated imaging. Also the analysis step is time consuming and requires pictures with good contrast from spheroid to matrix in order to make use of Photoshops ability to automatically recognize the border of the spheroid. In case the contrast is too low, one can easily adapt the brightness and contrast using the LEVELS and CURVES commands in Photoshop. Another way to increase the contrast would be the use a vital fluorescent dye.
As an alternative way of quantification, one could draw the area around the spheroid manually using Image J. An advance of Image J is that it is freeware (http://rsbweb.nih.gov/ij/). However, we found the manual drawing of the irregular shape of the invaded spheroids in Image J a time consuming step compared to Photoshop's Quick Selection Tool.
The protocol can be adapted to investigate invasion of other cell lines, provided that the cells are able to form spheroids.Furthermore, the optimal concentration of TGF-β to induce invasion of the cell line might be different. In all our cell lines, TGF-β induces invasion at 5 ng/ml, although M4 performs better when using 2 ng/ml.
In addition, this assay can be adapted to measure invasive responses to other growth factors, such as epithelial growth factor (EGF) or hepatocyte growth factor (HGF).
In our assays the basal and TGF-β-induced invasion was strongly inhibited by treatment with SB-431542, an inhibitor of type I receptor for TGF-β. This is a proof of principle that chemical inhibitors can be used in this assay. Other chemical inhibitors, such as MMP inhibitors, have also been used successfully at concentrations recommended by the manufacturer for monolayer cell culture.
Upon mastering this techniques, one can test the effect of chemical inhibitors, knockdown or overexpression of genes on invasion. Furthermore, by scaling up the assay to a 24 well format, one can isolate RNA using a phenol-chloroform-based method (e.g. Trizol® or Tripure) followed by a silica-column based clean-up This RNA can be used for quantitative real-time PCR.
Our spheroid invasion assay resembles the in vivo process more closely than 2D invasion models, because cells in spheroids are in different metabolic states and interact in more natural fashion with their surroundings10. We have performed Propidium Iodide and Fluorescein DiAcetate staining to check for dead and living cells after the invasion assay and observed that similarly to the in vivo situation, the cells in the center are dead and necrotic, whereas the cells at the outer edge are metabolically active.
We used type I collagen rather then matrigel, because several reports have shown that the composition of extracellular matrix in breast cancer is often altered, resulting in fibrotic stiff foci with a high collagen I content. It has been demonstrated that increased collagen I content promotes breast cancer formation and invasion15 and is associated with greater incidence of metastasis16. Many tumour cells thus have to invade through a collagen I rich environment in order to metastasize.
Several 3D models have been developed over the past decades. Cells can be either completely embedded within in a matrix or placed on top of a matrix or a polymeric scaffold17,18. In a 3D model developed by Bissell and co-workers, cells were grown in a reconstituted basement membrane (rBM) matrix. This model provides a rapid assay to distinguish between normal and malignant mammary epithelium, but focuses on cell morphology19,20. Morphogenesis and organization of the distinct MCF10A cell lines inversely correlated with malignancy21,22. In other 3D models multicellular spheroids showed the same resistance to cytotoxic drugs as their parental cell line in vivo, whereas cells in monolayers failed to do so11. Also 3D cultures of MCF10A cell lines have been used to assess sensitivity to kinase inhibitors23. Our spheroid model complements these assays by specifically focusing on invasion.
No conflicts of interest.
We are grateful to Ken Iwata (OSI Pharmaceuticals, New York, USA) for reagents and Fred Miller (Barbara Ann Karmanos Cancer Intitute, Detroit, USA) for the cell lines.
|pH indicator strips||Merck & Co., Inc.||9533|
|96-well suspension plates||Greiner Bio-One||650 185|
|96-well adhesion TC plates||Greiner Bio-One||655 180|
You must be signed in to post a comment. Please sign in or create an account.